Admelog® (insulin lispro) – New drug approval
December 11, 2017 – The FDA announced the approval of Sanofi’s Admelog (insulin lispro) injection to improve glycemic control in adults and pediatric patients 3 years and older with type 1 diabetes mellitus (T1DM) and adults with type 2 diabetes mellitus (T2DM).
Top